drugset / Trial / NCT00626743
Phase I Study to Investigate the Effect on the Blood Pressure After Oral Administration of SK3530 and Amlodipine
RandomizedCrossoverQuadruple-blindTreatment
Summary
To assess the pharmacodynamic effects of co-administrated SK3530 (PDE5 inhibitor) and Amlodipine, phase I study in Hypertensive patient was designed.
Timeline
- Start
- 2008-05
- Primary completion
- 2009-05
- Completion
- 2011-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Mirodenafil | Small molecule | 100 mg | Oral |
| Background | Amlodipine | Other / unclassified | — | Oral |